Equities analysts forecast that Masimo Co. (NASDAQ:MASI – Get Rating) will post $293.58 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Masimo’s earnings, with estimates ranging from $285.40 million to $301.76 million. Masimo reported sales of $299.04 million in the same quarter last year, which indicates a negative year-over-year growth rate of 1.8%. The firm is expected to issue its next quarterly earnings report after the market closes on Monday, January 1st.
According to Zacks, analysts expect that Masimo will report full year sales of $1.35 billion for the current year. For the next fiscal year, analysts expect that the company will post sales of $1.49 billion, with estimates ranging from $1.47 billion to $1.52 billion. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that follow Masimo.
Masimo (NASDAQ:MASI – Get Rating) last released its earnings results on Tuesday, February 15th. The medical equipment provider reported $1.21 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.10 by $0.11. The business had revenue of $327.58 million for the quarter, compared to analyst estimates of $320.75 million. Masimo had a return on equity of 16.06% and a net margin of 18.53%. The company’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.98 earnings per share.
In other Masimo news, Director Adam Mikkelson sold 600 shares of the business’s stock in a transaction on Monday, January 24th. The stock was sold at an average price of $214.80, for a total transaction of $128,880.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 9.10% of the stock is currently owned by insiders.
Several large investors have recently modified their holdings of MASI. Janney Montgomery Scott LLC lifted its position in shares of Masimo by 2.1% in the third quarter. Janney Montgomery Scott LLC now owns 5,837 shares of the medical equipment provider’s stock valued at $1,580,000 after acquiring an additional 120 shares in the last quarter. GWM Advisors LLC lifted its position in shares of Masimo by 4.6% in the third quarter. GWM Advisors LLC now owns 1,556 shares of the medical equipment provider’s stock valued at $421,000 after acquiring an additional 68 shares in the last quarter. Nordea Investment Management AB lifted its position in shares of Masimo by 100.0% in the third quarter. Nordea Investment Management AB now owns 4,958 shares of the medical equipment provider’s stock valued at $1,350,000 after acquiring an additional 2,479 shares in the last quarter. AE Wealth Management LLC lifted its position in shares of Masimo by 10.9% in the third quarter. AE Wealth Management LLC now owns 1,694 shares of the medical equipment provider’s stock valued at $459,000 after acquiring an additional 166 shares in the last quarter. Finally, Asset Management One Co. Ltd. lifted its position in shares of Masimo by 59.9% in the third quarter. Asset Management One Co. Ltd. now owns 35,784 shares of the medical equipment provider’s stock valued at $9,685,000 after acquiring an additional 13,399 shares in the last quarter. Institutional investors and hedge funds own 82.82% of the company’s stock.
NASDAQ:MASI opened at $124.92 on Friday. The firm has a market cap of $6.93 billion, a P/E ratio of 31.39 and a beta of 0.89. The stock’s 50 day simple moving average is $148.96 and its 200-day simple moving average is $226.61. Masimo has a 12-month low of $124.65 and a 12-month high of $305.21.
Masimo Company Profile (Get Rating)
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.
- Get a free copy of the StockNews.com research report on Masimo (MASI)
- 3 Resilient Stocks to Buy for Retirement
- MarketBeat: Week in Review 4/18 – 4/22
- Tractor Supply Company Reaps What It Sows
- Snap (NYSE: SNAP) Gives Investors A Mixed Bag
- MarketBeat Podcast: 3 Stocks Flashing Buy Signals
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.